Calamos Advisors LLC Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Calamos Advisors LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 34.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 123,108 shares of the medical equipment provider’s stock after acquiring an additional 31,249 shares during the quarter. Calamos Advisors LLC’s holdings in Intuitive Surgical were worth $41,532,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Vanguard Group Inc. lifted its holdings in shares of Intuitive Surgical by 0.7% during the 3rd quarter. Vanguard Group Inc. now owns 29,868,227 shares of the medical equipment provider’s stock valued at $8,730,184,000 after buying an additional 196,316 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 1.0% during the 1st quarter. Geode Capital Management LLC now owns 6,444,995 shares of the medical equipment provider’s stock valued at $1,642,287,000 after buying an additional 61,659 shares during the period. Morgan Stanley lifted its holdings in shares of Intuitive Surgical by 29.9% during the 4th quarter. Morgan Stanley now owns 5,866,613 shares of the medical equipment provider’s stock valued at $1,556,706,000 after buying an additional 1,351,002 shares during the period. Jennison Associates LLC lifted its holdings in shares of Intuitive Surgical by 6.4% during the 3rd quarter. Jennison Associates LLC now owns 4,585,190 shares of the medical equipment provider’s stock valued at $1,340,205,000 after buying an additional 274,692 shares during the period. Finally, Invesco Ltd. lifted its holdings in shares of Intuitive Surgical by 6.6% during the 3rd quarter. Invesco Ltd. now owns 3,750,490 shares of the medical equipment provider’s stock valued at $1,096,231,000 after buying an additional 232,205 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Down 0.4 %

Shares of NASDAQ:ISRG traded down $1.54 on Thursday, hitting $372.63. 2,272,280 shares of the company were exchanged, compared to its average volume of 1,644,402. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $403.76. The stock’s 50 day moving average price is $387.56 and its 200 day moving average price is $342.39. The firm has a market capitalization of $132.08 billion, a P/E ratio of 74.39, a price-to-earnings-growth ratio of 5.88 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. The company’s revenue was up 11.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.00 earnings per share. On average, equities analysts predict that Intuitive Surgical, Inc. will post 4.93 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Gary S. Guthart sold 24,325 shares of the business’s stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $376.06, for a total transaction of $9,147,659.50. Following the completion of the sale, the chief executive officer now owns 9,425 shares of the company’s stock, valued at $3,544,365.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Gary S. Guthart sold 24,325 shares of the company’s stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $376.06, for a total transaction of $9,147,659.50. Following the completion of the sale, the chief executive officer now owns 9,425 shares of the company’s stock, valued at approximately $3,544,365.50. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, VP Marshall Mohr sold 108,790 shares of the company’s stock in a transaction dated Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the sale, the vice president now directly owns 26,877 shares of the company’s stock, valued at approximately $10,349,795.16. The disclosure for this sale can be found here. Over the last quarter, insiders sold 248,418 shares of company stock worth $95,927,097. Company insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Stifel Nicolaus upped their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, April 8th. Citigroup increased their price target on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Truist Financial raised their price objective on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Mizuho raised their price objective on Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. Finally, Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a research note on Friday, January 19th. Five research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $375.70.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.